Comparison of smoked marijuana and oral Δ9-tetrahydrocannabinol in humans

被引:44
作者
Hart, CL
Ward, AS
Haney, M
Comer, SD
Foltin, RW
Fischman, MW
机构
[1] New York State Psychiat Inst & Hosp, Div Subst Abuse, Unit 120, New York, NY 10032 USA
[2] Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA
关键词
cannabis; marinol; subjective effects; human; food intake; delta-9-tetrahydrocannabinol tolerance dependence; abstinence;
D O I
10.1007/s00213-002-1231-y
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Rationale: Although smoked marijuana contains at least 60 cannabinoids, Delta(9)-tetrahydrocannabinol (Delta(9)-THC) is presumed to be the cannabinoid primarily responsible for many marijuana-related effects, including increased food intake and subjective effects. Yet, there has been no systematic comparison of repeated doses of oral Delta(9)-THC with repeated doses of smoked marijuana in the same individuals. Objective: To compare the effects of oral Delta(9)-THC and smoked marijuana in humans under controlled laboratory conditions. Methods: Eleven healthy research volunteers, who reported smoking an average of six marijuana cigarettes per day, completed an 18-day residential study. Marijuana cigarettes (3.1% Delta(9)-THC, q.i.d.) were smoked or Delta(9)-THC (20 mg, q.i.d.) was taken orally using a staggered, double-blind, double-dummy procedure for three consecutive days. Four days of placebo administration separated each active drug condition. Psychomotor task performance, subjective effects, and food intake were measured throughout the day. Results: Relative to placebo baseline, oral Delta(9)-THC and smoked marijuana produced similar subjective-effect ratings (e.g., "high" and "mellow"), although some effects of smoked marijuana were more pronounced and less prone to the development of tolerance. Additionally, participants reported "negative" subjective effects (e.g., "irritable" and "miserable") during the days after smoking marijuana but not after oral Delta(9)-THC. Both drugs increased food intake for 3 days of drug administration, but had little effect on psychomotor performance. Conclusion: These results indicate that the behavioral profile of effects of smoked marijuana (3.1% Delta(9)-THC is similar to the effects of oral Delta(9)-THC (20 mg), with some subtle differences.
引用
收藏
页码:407 / 415
页数:9
相关论文
共 30 条
  • [1] BABOR TF, 1975, ARCH GEN PSYCHIAT, V32, P1548
  • [2] Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia
    Beal, JE
    Olson, R
    Lefkowitz, L
    Larenstein, L
    Bellman, P
    Yangco, B
    Morales, JO
    Murphy, R
    Powderly, W
    Plasse, TF
    Mosdell, KW
    Shepard, KV
    [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1997, 14 (01) : 7 - 14
  • [3] Marijuana abstinence effects in marijuana smokers maintained in their home environment
    Budney, AJ
    Hughes, JR
    Moore, BA
    Novy, PL
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2001, 58 (10) : 917 - 924
  • [4] REINFORCING AND SUBJECTIVE EFFECTS OF ORAL DELTA-9-THC AND SMOKED MARIJUANA IN HUMANS
    CHAIT, LD
    ZACNY, JP
    [J]. PSYCHOPHARMACOLOGY, 1992, 107 (2-3) : 255 - 262
  • [5] Effect of fluoxetine on food intake of humans living in a residential laboratory
    Foltin, RW
    Haney, M
    Comer, SD
    Fischman, MW
    [J]. APPETITE, 1996, 27 (02) : 165 - 181
  • [6] MARIJUANA AND COCAINE INTERACTIONS IN HUMANS - CARDIOVASCULAR CONSEQUENCES
    FOLTIN, RW
    FISCHMAN, MW
    PEDROSO, JJ
    PEARLSON, GD
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1987, 28 (04) : 459 - 464
  • [7] OBSERVATIONS ON THE EFFECTS OF 4 WEEKS OF HEAVY MARIHUANA SMOKING ON GROUP-INTERACTION AND INDIVIDUAL BEHAVIOR
    GEORGOTAS, A
    ZEIDENBERG, P
    [J]. COMPREHENSIVE PSYCHIATRY, 1979, 20 (05) : 427 - 432
  • [8] Haney M, 1997, BEHAV PHARMACOL, V8, P101
  • [9] Abstinence symptoms following smoked marijuana in humans
    Haney, M
    Ward, AS
    Comer, SD
    Foltin, RW
    Fischman, MW
    [J]. PSYCHOPHARMACOLOGY, 1999, 141 (04) : 395 - 404
  • [10] Abstinence symptoms following oral THC administration to humans
    Haney, M
    Ward, AS
    Comer, SD
    Foltin, RW
    Fischman, MW
    [J]. PSYCHOPHARMACOLOGY, 1999, 141 (04) : 385 - 394